Elevated sulfatide excretion in compound heterozygotes of metachromatic leukodystrophy and ASA-pseudodeficiency allele

Clinical Biochemistry

Volumn 30, Issue 4, 1997, Pages 325-331

  Ługowska, Agnieszka ^a   Tylki Szymańska, Anna ^a   Berger, Johannes ^b   Molzer, Brunhilde ^b  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b NONE

Author keywords

Arylsulfatase A; Arylsulfatase A pseudodeficiency; Lysosomal storage disease; Metachromatic leukodystrophy; Sulfatide

Indexed keywords

ARYLSULFATASE; SULFATIDE;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; GLYCOSYLATION; HUMAN; LEUKODYSTROPHY; LIPID METABOLISM; LIPOGENESIS; LYSOSOME STORAGE DISEASE; MALE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; THIN LAYER CHROMATOGRAPHY;

ADOLESCENT; ADULT; ALLELES; CEREBROSIDE-SULFATASE; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HETEROZYGOTE; HUMANS; INFANT; LEUKODYSTROPHY, METACHROMATIC; MALE; MIDDLE AGED; SULFOGLYCOSPHINGOLIPIDS;

EID: 0342378082     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(97)00033-7     Document Type: Article

References (27)

1. Kolodny EH, Fluharty AL. Metachromatic leukodystrophy and multiple sulfatase deficiency: Sulfatide lipidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds): "The Metabolic Basis of Inherited Disease", 6th Ed. New York: Mc Graw-Hill, pp 1721-50, 1989.
2. Gieselmann V, Zlotogora J, Harris A, Wenger DA, Morris CP. Molecular Genetics of Metachromatic Leukodystrophy. Hum Mutat 1994; 4: 233-42.
3. Luyten JA, Wenink PW, Steenbergen-Spanjers GC, et al. Metachromatic leukodystrophy: a 12-bp deletion in exon 2 of the arylsulfatase A gene in a late infantile variant. Hum Genet 1995; 96: 357-60.
4. Regis S, Carrozzo R, Filocamo M, Serra G, Mastropaolo C, Gatti R. An AT-deletion causing a frameshift in the arylsulfatase A gene of a late infantile metachromatic leukodystrophy patient. Hum Genet 1995; 96: 233-5.
5. Zlotogora J, Bach G, Bösenberg C, Barak Y, von Figura K, Gieselmann V. Molecular basis of late infantile metachromatic leukodystrophy in the Habbanite Jews. Hum Mutat 1995; 5: 137-43.
6. Pastor-Soler NM, Rafi MA, Hoffman JD, Hu D, Wenger DA. Metachromatic leukodystrophy in the Navajo Indian population: a splice site mutation in intron 4 of the arylsulfatase A gene. Hum Mutat 1994; 4: 199-207.
7. Heinisch U, Zlotogora J, Kafert S, Gieselmann V. Multiple mutations are responsible for the high frequency of metachromatic leukodystrophy in a small geographic area. Am J Hum Genet 1995; 56: 51-7.
8. Kappler J, Sommerlade HJ, von Figura K, Gieselmann V. Complex arylsulfatase A alleles causing metachromatic leukodystrophy. Hum Mutat 1994; 4: 119-27.
9. Gieselmann V, Polten A, Kreysing J, et al. Mutations in arylsulfatase A alleles causing metachromatic leukodystrophy. Brain Dysfunction 1991; 4: 235-43.
10. Polten A, Fluharty AL, Fluharty CB, et al. Molecular basis of different forms of metachromatic leukodystrophy. N Engl J Med 1991; 324: 18-22.
11. Hohenschutz C, Eich P, Friedl W, Waheed A, Conzelmann E, Propping P. Pseudodeficiency of arylsulfatase A: a common genetic polymorphism with possible disease implications. Hum Genet 1989; 82: 45-8.
12. Kappler J, Leinekugel P, Conzelmann E, et al. Genotype-phenotype relationship in various degrees of arylsulfatase A deficiency. Hum Genet 1991; 86: 463-70.
13. Kampine JP, Brady RO, Kanfer JN, Feld M, Shapiro D. Diagnosis of Gaucher's disease and Niemann-Pick disease with small samples of venous blood. Science 1966: 155: 86-8.
14. Fallon HJ, Frei E III, Davidson JD, Trier JS, Burk D. Leukocyte preparations from human blood: Evaluation of their morphologic and metabolic state. J Lab Clin Med 1962; 59: 779-91.
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
16. Bass NH, Witmer EJ, Dreifuss FE. A pedigree study of metachromatic leukodystrophy. Neurology 1970; 20: 52-62.
17. 1-gangliosidosis. A variant with high activity of hepatic neutral β-galactosidase. Eur J Ped 1976; 122: 177-86.
18. Molzer B, Sundt-Heller R, Kainz-Korschinsky M, Zobel M. Elevated sulfatide excretion in heterozygotes of metachromatic leukodystrophy: dependence on reduction of arylsulfatase A activity. Am J Med Genet 1992; 44: 523-6.
19. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
20. Gieselmann V. An assay for the rapid detection of the arylsulfatase A pseudodeficiency allele facilitates diagnosis and genetic counseling for metachromatic leukodystrophy. Hum Genet 1991; 86: 251-5.
21. Harzer K. Inheritance of the enzyme deficiency in three neurolipidoses: variant 0 of Tay-Sachs disease (Sandhoff s disease), classic Tay-Sachs disease, and metachromatic leukodystrophy. Identification of the heterozygous carriers. Humangenetik 1973; 20: 9-24.
22. Francis GS, Bonni A, Shen N et al. Metachromatic leukodystrophy: multiple nonfunctional and pseudodeficiency alleles in a pedigree: problems with diagnosis and counseling. Ann Neurol 1993; 34: 212-18.
23. Leistner S, Young E, Meaney C, Winchester B. Pseudodeficiency of arylsulphatase A: Strategy for clasification of genotype in families of subjects with low ASA activity and neurological symptoms. J Inher Metab Dis 1995; 18: 710-16.
24. Natowicz MR, Prence EM, Chaturvedi P, Newburg DS. Urine sulfatides and the diagnosis of metachromatic leukodystrophy. Clin Chem 1996; 42: 232-8.
25. Leinekugel P, Michel S, Conzelmann E, Sandhoff K. Quantitative correlation between the residual activity of β-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet 1992; 88: 513-23.
26. Penzien JM, Kappler J, Herschkowitz N, et al. Compound heterozygosity for metachromatic leukodystrophy and arylsulfatase A pseudodeficiency alleles is not associated with progressive neurological disease. Am J Hum Genet 1993; 52: 557-64.
27. Conzelmann E, Sandhoff K. Partial enzyme deficiences: residual activities and the development of neurological disorders. Dev Neurosci 1983/84; 6: 58-71.